Page last updated: 2024-12-10

3,3'-diallyldiethylstilbestrol

Description

3,3'-diallyldiethylstilbestrol: RN given refers to (E)-isomer; RN for cpd without isomeric designation not available 12/89 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3036605
CHEMBL ID230346
SCHEMBL ID10016276
MeSH IDM0170940

Synonyms (16)

Synonym
3,3'-diallyldiethylstilbestrol
4-[(1e)-1-ethyl-2-(4-hydroxy-3-prop-2-enylphenyl)but-1-enyl]-2-prop-2-enylphenol
2-allyl-4-[(e)-2-(3-allyl-4-hydroxy-phenyl)-1-ethyl-but-1-enyl]phenol
CHEMBL230346
w6u293x04b ,
unii-w6u293x04b
4870-88-6
dades
phenol, 4,4'-(1,2-diethyl-1,2-ethanediyl)bis(2-(2-propenyl)-, (e)-
SCHEMBL10016276
4,4'-stilbenediol, 3,3'-diallyl-.alpha.,.alpha.'-diethyl-, (e)-
phenol, 4,4'-((1e)-1,2-diethyl-1,2-ethenediyl)bis(2-(2-propenyl)-
4,4'-((1e)-1,2-diethyl-1,2-ethenediyl)bis(2-(2-propen-1-yl)phenol)
phenol, 4,4'-((1e)-1,2-diethyl-1,2-ethenediyl)bis(2-(2-propen-1-yl)-
(e)-4,4'-(hex-3-ene-3,4-diyl)bis(2-allylphenol)
Q27891430
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID292084Cytotoxicity against human PBM cells2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID292083Antiviral activity against HIV1 in human PBM cells2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID292081Antiproliferative activity against mouse SVR cells at 10 ug/mL after 72 hrs2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID292082Antiproliferative activity against mouse SVR cells at 15 ug/mL after 72 hrs2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID1552550Partition coefficient, log P of the compound2019Bioorganic & medicinal chemistry, 08-15, Volume: 27, Issue:16
Anti-proliferative activity and structure-activity relationship of honokiol derivatives.
AID292086Cytotoxicity against Vero cells2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID292087Inhibition of tumor growth in SVR cells bearing mouse up to 100 mg/kg, ip after 30 days2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID292085Cytotoxicity against human CEM cells2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID292088Toxicity against mouse up to 100 mg/kg, ip after 30 days2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.64 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
chemdatabank.com